SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Ontology highlight
ABSTRACT: Overexpression of the oncogene HER2 occurs in 20-30% of invasive breast cancer and is associated with poor prognosis. A number of different splice variants of HER2 have been identified which produce functionally different proteins. Previously these splice variants have been investigated separately, but in the present study we collectively look at the expression and regulation of a group of HER2 splice variants produced by a splicing hotspot. Initial investigation in a cohort of tumor samples showed large variations in HER2 variant expression between patient samples. RNA interference studies identified 2 splicing factors involved in the regulation of splicing within this region, hnRNP H1 and SRSF3. siRNA targeting hnRNP H1 increases levels of X5 and the oncogenic variant Δ16HER2. Furthermor
SUBMITTER: Gautrey H
PROVIDER: S-EPMC4829299 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA